FDA Approves ATOVAQUONE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. received FDA approval for oral atovaquone, reinforcing market expectations for increased generic penetration and pressure on pricing against branded competitors in the infectious disease sector.